{"id":4212,"date":"2025-09-23T15:24:46","date_gmt":"2025-09-23T14:24:46","guid":{"rendered":"https:\/\/neuromed-europe.com\/actualites\/neuromed-at-anllf-2025-the-french-eeg-solution\/"},"modified":"2026-02-02T12:22:10","modified_gmt":"2026-02-02T11:22:10","slug":"neuromed-at-anllf-2025-the-french-eeg-solution","status":"publish","type":"post","link":"https:\/\/neuromed-europe.com\/en\/news\/neuromed-at-anllf-2025-the-french-eeg-solution\/","title":{"rendered":"Neuromed at ANLLF 2025: The French EEG solution"},"content":{"rendered":"\n<h3 class=\"wp-block-heading\"><strong>A congress dedicated to epileptology, an opportunity for diagnostic innovations<\/strong><\/h3>\n\n<p>From <strong>September 26 to 28, 2025<\/strong>, the <strong> Association des Neurologues Lib\u00e9raux de Langue Fran\u00e7aise (<a href=\"https:\/\/anllf.org\/anllf\/qui-sommes-nous\/\" data-type=\"link\" data-id=\"https:\/\/anllf.org\/anllf\/qui-sommes-nous\/\" target=\"_blank\" rel=\"noreferrer noopener\">ANLLF<\/a>)<\/strong> will be holding its annual congress in <strong>Amiens<\/strong>, a unifying event for <strong>neurologists, epileptologists and healthcare professionals<\/strong> specializing in the management of epilepsy. In France, this pathology affects <strong>some 600,000 people<\/strong> (source: <em>Haute Autorit\u00e9 de Sant\u00e9, 2021<\/em>), with a major challenge: <strong>reducing diagnostic delays<\/strong>, since almost <strong>30% of epilepsy patients<\/strong> do not benefit from an EEG assessment within six months of the onset of symptoms<em>(INSERM study, 2022<\/em>). <\/p>\n\n<p>In this context, <strong><a href=\"https:\/\/neuromed-europe.com\/en\/about\/\" data-type=\"page\" data-id=\"2196\">Neuromed<\/a><\/strong>a French company specializing in <strong>EEG technologies<\/strong>, will be presenting its <strong>new range of electroencephalographs<\/strong> developed and manufactured in the <strong>Vaucluse<\/strong> region <strong>(84)<\/strong>. Already tested in hospitals &#8211; notably <strong>the H\u00f4pital Europ\u00e9en de Marseille and CHU Cochin (Paris)<\/strong> &#8211; these devices feature three key advantages: <\/p>\n\n<ul class=\"wp-block-list\">\n<li><strong>Simplified connection<\/strong> (plug-and-play, no complex calibration).<\/li>\n\n\n\n<li><strong>Optimized signal quality<\/strong> (reduced artifacts for more reliable interpretation).<\/li>\n\n\n\n<li><strong>No software licenses<\/strong>, limiting recurring costs for establishments.<\/li>\n<\/ul>\n\n<p>An approach that meets the <strong>concrete needs of neurology departments<\/strong>, where <strong>speed, precision and budget control<\/strong> are priorities.<\/p>\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n<h3 class=\"wp-block-heading\"><strong>Clinically validated performance<\/strong><\/h3>\n\n<p>Neuromed devices have been <strong>evaluated under real-life conditions<\/strong> in several hospitals, including <strong>the H\u00f4pital Europ\u00e9en de Marseille<\/strong>. Feedback from the medical teams highlights : <\/p>\n\n<ul class=\"wp-block-list\">\n<li><strong>A 40% reduction in<\/strong> exam <strong>preparation time<\/strong>, thanks to an intuitive interface.<\/li>\n\n\n\n<li><strong>Improved detection of epileptiform activity<\/strong>, with sensitivity comparable to high-end systems on the market<em>(Neuromed internal data, 2023<\/em>).<\/li>\n\n\n\n<li><strong>Simplified maintenance<\/strong>, with <strong>responsive after-sales service<\/strong> (response time within 48 hours, compared with 7 to 10 days for some international competitors).<\/li>\n<\/ul>\n\n<p>Unlike other manufacturers, whose solutions often require <strong>costly annual licenses<\/strong> (up to \u20ac10,000\/year), Neuromed offers a <strong>transparent business model<\/strong>, with no hidden costs. A decisive advantage for <strong>public hospitals and private clinics<\/strong>, faced with <strong>increasing budget constraints<\/strong>. <\/p>\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n<h3 class=\"wp-block-heading\"><strong>Made in France, a strategic asset for healthcare establishments<\/strong><\/h3>\n\n<p>Over and above technical performance, the <strong>choice of 100% French production<\/strong> (manufacturing site in Vaucluse) offers concrete advantages:<\/p>\n\n<ul class=\"wp-block-list\">\n<li><strong>Short delivery times<\/strong> (2 to 4 weeks, compared with several months for imports).<\/li>\n\n\n\n<li><strong>Full compliance with European standards<\/strong> (CE class IIa certification).<\/li>\n\n\n\n<li><strong>Local support<\/strong>, with a technical team available for <strong>rapid training and troubleshooting<\/strong>.<\/li>\n<\/ul>\n\n<p>This commitment is in line with the government&#8217;s <strong>drive for medical sovereignty<\/strong>, particularly in the wake of the health crisis<em>(Plan France 2030, health section<\/em>).<\/p>\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n<h3 class=\"wp-block-heading\"><strong>Meet Neuromed at ANLLF 2025<\/strong><\/h3>\n\n<p>Professionals wishing to <strong>discover these innovations<\/strong> will be able to :<\/p>\n\n<ul class=\"wp-block-list\">\n<li><strong>Visit the Neuromed stand<\/strong> (location) for <strong>live demonstrations<\/strong>.<\/li>\n\n\n\n<li><strong>Discuss<\/strong> <strong>hospital use cases<\/strong><strong>with engineers and medical managers<\/strong>.<\/li>\n\n\n\n<li><strong>Benefit from a free trial offer<\/strong> in their establishment.<\/li>\n<\/ul>\n\n<p><em>\u2192 To arrange an appointment :<a href=\"https:\/\/neuromed-europe.com\/en\/contact\/videoconference\/\" data-type=\"page\" data-id=\"1568\" target=\"_blank\" rel=\"noreferrer noopener\">[Make an appointment now<\/a>]<\/em><\/p>\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n<p><strong>Neuromed &#8211; French EEG expertise at the service of healthcare professionals.<\/strong><br\/><em>ANLLF Congress, Amiens, September 26-28, 2025.<\/em><\/p>\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A congress dedicated to epileptology, an opportunity for diagnostic innovations From September 26 to 28, 2025, the Association des Neurologues Lib\u00e9raux de Langue Fran\u00e7aise (ANLLF) will be holding its annual congress in Amiens, a unifying event for neurologists, epileptologists and healthcare professionals specializing in the management of epilepsy. In France, this pathology affects some 600,000 people (source: Haute Autorit\u00e9 de &#8230; <\/p>\n<div><a href=\"https:\/\/neuromed-europe.com\/en\/news\/neuromed-at-anllf-2025-the-french-eeg-solution\/\" class=\"more-link\">Read More<\/a><\/div>\n","protected":false},"author":3,"featured_media":4205,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"","_seopress_titles_title":"Neuromed at ANLLF 2025 Amiens: The French EEG solution","_seopress_titles_desc":"From September 26 to 28, 2025, the Association des neurologues lib\u00e9raux de langue fran\u00e7aise (ANLLF) will be holding its annual congress in Amiens...","_seopress_robots_index":"","footnotes":""},"categories":[150,148],"tags":[],"class_list":["post-4212","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-events","category-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/neuromed-europe.com\/en\/wp-json\/wp\/v2\/posts\/4212","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neuromed-europe.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neuromed-europe.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neuromed-europe.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/neuromed-europe.com\/en\/wp-json\/wp\/v2\/comments?post=4212"}],"version-history":[{"count":0,"href":"https:\/\/neuromed-europe.com\/en\/wp-json\/wp\/v2\/posts\/4212\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neuromed-europe.com\/en\/wp-json\/wp\/v2\/media\/4205"}],"wp:attachment":[{"href":"https:\/\/neuromed-europe.com\/en\/wp-json\/wp\/v2\/media?parent=4212"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neuromed-europe.com\/en\/wp-json\/wp\/v2\/categories?post=4212"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neuromed-europe.com\/en\/wp-json\/wp\/v2\/tags?post=4212"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}